A Phase 1b/2 study of galunisertib in combination with nivolumab in solid tumors and NSCLC

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2019)

引用 0|浏览21
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要